Multimodal Cardiac Imaging of a Sudden Cardiac Death Survivor From Central America
- PMID: 40579098
- PMCID: PMC12273848
- DOI: 10.1016/j.jaccas.2025.104203
Multimodal Cardiac Imaging of a Sudden Cardiac Death Survivor From Central America
Abstract
Background: Sudden cardiac death (SCD) in a nonimmunosuppressed individual from El Salvador who had visited 2 Trypanosoma cruzi seropositive siblings raised clinical suspicion for Chagas disease.
Case summary: A 61-year-old male SCD survivor presented with electrocardiogram conduction abnormalities, cardiomegaly, myocardial necrosis with basal inferolateral aneurysm formation (echocardiography, left ventriculography), and sluggish contrast flow in the absence of coronary obstruction. Cardiac magnetic resonance defined the extent of myocardial fibrosis (delayed enhancement) from microvascular disease and guided endomyocardial biopsy. T. cruzi serology studies and circulating inflammatory markers supported late-stage Chagas cardiomyopathy.
Discussion: Patients in T. cruzi-endemic regions are at an increased risk of developing Chagas cardiomyopathy, predisposing to SCD. Multimodal imaging provided indications for antiparasitic therapy to reduce disease progression and for dual-chamber implantable cardioverter defibrillator for secondary prevention in high-risk patients (Rassi score = 13).
Take-home message: In SCD survivors with Chagas cardiomyopathy, multimodal cardiac imaging: 1) improves early management; 2) guides antiparasitic therapy; and 3) adds prognostic value.
Keywords: cardiac magnetic resonance; cardiomypathy; coronary angiography.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures




Similar articles
-
Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis.Eur J Prev Cardiol. 2017 Jul;24(11):1220-1230. doi: 10.1177/2047487317702519. Epub 2017 May 9. Eur J Prev Cardiol. 2017. PMID: 28482693
-
CarDiac magnEtic Resonance for prophylactic Implantable cardioVerter defibrillAtor ThErapy in Non-Dilated Left Ventricular Cardiomyopathy: a sub-study from the DERIVATE registry.Eur Heart J Cardiovasc Imaging. 2025 Jun 30;26(7):1233-1241. doi: 10.1093/ehjci/jeaf043. Eur Heart J Cardiovasc Imaging. 2025. PMID: 39899463 Free PMC article.
-
Sudden Cardiac Death.2024 Mar 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 29939631 Free Books & Documents.
-
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. doi: 10.3310/hta10270. Health Technol Assess. 2006. PMID: 16904046
-
Unexpected case of chagas disease reactivation in endomyocardial biopsy for evaluation of cardiac allograft rejection.Cardiovasc Pathol. 2022 Mar-Apr;57:107394. doi: 10.1016/j.carpath.2021.107394. Epub 2021 Nov 3. Cardiovasc Pathol. 2022. PMID: 34742866
References
-
- Nunes M.C.P., Beaton A., Acquatella H., et al. Chagas cardiomyopathy: an update of current clinical knowledge and management. A scientific statement from the American Heart Association (Endorsed by the Inter-American Society of Cardiology) Circulation. 2016;138:e169–e209. doi: 10.1161/CIR.0000000000000599. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources